NASDAQ:RAIN

Rain Therapeutics Stock Forecast

etoro logo Buy RAIN
*Your capital is at risk
$2.20
+0.0100 (+0.457%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of RAIN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAIN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Friday for Rain Therapeutics Inc. stock after gaining 0.457%
(Updated on Jun 05, 2026)

Sell candidate since Jun 02, 2026 Loss -5.17%

The Rain Therapeutics Inc. stock price gained 0.457% on the last trading day (Friday, 5th Jun 2026), rising from $2.19 to $2.20. During the last trading day the stock fluctuated 9.09% from a day low at $2.09 to a day high of $2.28. The price has fallen in 5 of the last 10 days and is down by -10.2% for this period. Volume fell on the last day by -16 thousand shares and in total, 10 thousand shares were bought and sold for approximately $22.66 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.32 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -34.56% during the next 3 months and, with a 90% probability hold a price between $0.589 and $1.52 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RAIN Signals & Forecast

The Rain Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.25. On a fall, the stock will find some support from the long-term average at approximately $2.08. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -10.57%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Rain Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.02 and $2.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rain Therapeutics Inc. finds support just below today's level at $2.02. If this is broken, then the next support from accumulated volume will be at $2.01 and $1.88.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.190 between high and low, or 9.09%. For the last week the stock has had daily average volatility of 9.02%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAIN) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Rain Therapeutics Inc. to open at $2.19, and during the day (based on 14 day Average True Range), to move between $2.07 and $2.33, which gives a possible trading interval of +/-$0.269 (+/-13.04%) up or down from last closing price. If Rain Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.31 (5.00%) than the support at $2.02 (8.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rain Therapeutics Inc. stock A Buy?

Rain Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.590 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $2.19 ( 0.455%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAIN Performance

Trading levels for RAIN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.38 8.18%
R2 2.31 4.88%
R1 2.26 2.84%
Price 2.20
S1 2.12 -3.75%
S2 2.07 -5.79%
S3 2.00 -9.09%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.45 11.36%
R2 2.32 5.45%
R1 2.31 5.00%
Price 2.20
S1 2.02 -8.18%
S2 2.01 -8.64%
S3 1.88 -14.55%

FAQ

What is the symbol for Rain Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rain Therapeutics Inc. is RAIN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rain Therapeutics Inc. Stock.

What's the current price of Rain Therapeutics Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Rain Therapeutics Inc. (RAIN) share was $2.20.

What is the 52-week high and low for Rain Therapeutics Inc. Stock?
The 52-week high for Rain Therapeutics Inc. Stock is $8.50 and the 52-week low is $1.26.

What is the market capitalization of Rain Therapeutics Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Rain Therapeutics Inc. is 17.888M.
Click to get the best stock tips daily for free!
ABOUT RAIN THERAPEUTICS INC.
Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinica...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE